HIGHLIGHTS
- who: Yue Wu from the Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People`s Hospital (Affiliated People`s Hospital, Hangzhou Medical College), Zhejiang Province, Hangzhou, China have published the article: DEHP mediates drug resistance by metabolic reprogramming in colorectal cancer cells, in the Journal: (JOURNAL)
- what: The authors showed that DEHP could trigger the metabolic reprogramming of colorectal cancer cells promote cell growth and decrease fluorouracil (5-FU) sensitivity.
- how: These data indicated that DEHP administration leads to a significantly decreased in both glycolysis and glycolysis capacity.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.